Barrett's esophagus Autofuorescence imaging Narrow band imaging
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age > 18 years; 2. Prior diagnosis of BE defined as the presence of columnar lined epithelium in the tubular esophagus with specialised intestinal metaplasia on histological investigation; 3. Prior diagnosis of high-grade dysplasia or early cancer that was endoscopically inconspicuous according to the referring physician. Review of the pathology slides is not required for inclusion; 4. A minimum Barrett’s length of C>2M>2 or C4 according to the Prague C&M classification of the endoscopic appearance of BE; 4. Written informed consent.
Exclusion criteria
Exclusion criteria: 1. Presence of active erosive esophagitis > grade A according to the Los Angles classification of erosive esophagitis; 2. Description of an endoscopically visible suspicious lesion in the Barrett’s segment in the referring center; 3. Presence of conditions precluding histological sampling of the esophagus (e.g. esophageal varices, coagulation disorders, anticoagulant therapy); 4. At the first endoscopy: the presence of a type 0-I or type 0-III lesion or a lesion that, according to the discretion of the endoscopist, does not allow a delay in intervention for a period of 6 weeks (interval between the two cross-over endoscopies).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. The number of patients and the number of lesions with early neoplasia detected with SVE and ETMI; 2. The number of patients with early neoplasia detected with targeted biopsies only with ETMI and SVE. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. The sensitivity and positive predictive value (PPV) of HRE and AFI; 2. The reduction of false positive findings after NBI; 3. Negative predictive value of the combination of HRE and AFI and the reduction in false negative findings after. | — |
Contacts
Academic Medical Center Bldg. C2-210, Meibergdreef